| 注册
首页|期刊导航|中国药业|药物临床试验药物管理员核心能力评价指标体系构建及应用

药物临床试验药物管理员核心能力评价指标体系构建及应用

尹园园 蒋清青 汤晓华 毛巍然 陈霞

中国药业2026,Vol.35Issue(7):29-34,6.
中国药业2026,Vol.35Issue(7):29-34,6.DOI:10.3969/j.issn.1006-4931.2026.07.005

药物临床试验药物管理员核心能力评价指标体系构建及应用

Construction and Application of a Core Competency Assessment Index System for Drug Administrators in Drug Clinical Trials

尹园园 1蒋清青 1汤晓华 1毛巍然 1陈霞1

作者信息

  • 1. 重庆大学附属肿瘤医院临床研究中心·重庆大学附属肿瘤医院肿瘤转移与个体化诊治转化研究重庆市重点实验室,重庆 400030
  • 折叠

摘要

Abstract

Objective To construct a core competency assessment index system for drug administrators in drug clinical trials(hereinafter referred to as drug administrators)in China,and to evaluate the core competencies of drug administrators.Methods A preliminary core competency assessment index system was constructed through literature research and expert consultation methods from the perspectives of the role positioning,job responsibilities,and work scope of drug administrators,and the index system was modified and validated by the Delphi method.Based on the constructed assessment index system,an electronic questionnaire survey was conducted among drug administrators from 38 drug clinical trial institutions.Wilcoxon signed-rank test was used to compare the role-importance and self-competence scores scores of drug administrators in various indexes of core competencies.Results A total of 19 experts completed two rounds of Delphi expert inquiry,with expert positivity coefficients of 100.00%and 95.00%,expert authority coefficient of 0.929,and expert Kendall's W coordination coefficients of 0.236 and 0.278,respectively(all P<0.001).The core competency assessment index system of drug administrators consisted of three first-level indicators and thirty-five second-level indicators.A total of 95 questionnaires were distributed to 38 drug clinical trial institutions,and 95 valid questionnaires were collected,with an effective response rate of 100.00%.In the dimension of individual professional competency,two out of nine indicators showed a significant difference between self-competence score and role-importance score(P<0.05).In the dimension of drug management competency,three out of tweenty-one indicators showed a significant difference(P<0.05).In the dimension of quality control competency,one of five indicators showed a significant difference(P<0.05).Conclusion The core competency assessment index system of drug administrators constructed by the Delphi method can provide an objective and quantifiable basis for the assessment of drug administrators'core competencies,and can also provide a reference for the construction of a standardized drug administrator education and training system.

关键词

药物临床试验/药物管理员/核心能力/评价指标体系/德尔菲法

Key words

drug clinical trials/drug administrator/core competencies/assessment index system/Delphi method

分类

医药卫生

引用本文复制引用

尹园园,蒋清青,汤晓华,毛巍然,陈霞..药物临床试验药物管理员核心能力评价指标体系构建及应用[J].中国药业,2026,35(7):29-34,6.

基金项目

重庆市技术预见与制度创新项目[CSTB2023TFII-OIX0002]. ()

中国药业

1006-4931

访问量2
|
下载量0
段落导航相关论文